Gene variant protecting against Alzheimer's disease decreases plasma beta-amyloid levels
Gene variant protecting against Alzheimer’s disease decreases plasma beta-amyloid levels The APP gene variant protecting against Alzheimer’s disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant discovery, as many on-going drug trials in the field of Alzheimer’s disease focus on decreasing beta-amyloid levels in the brain tissue. According to…
Details